
Ashland Inc. (ASH) Analyst/Investor Day Transcript
Ashland Global Holdings Inc. offers specialized chemical solutions globally. The company is headquartered in Covington, Kentucky.
| Revenue (TTM) | $1.84B |
| Gross Profit (TTM) | $615.00M |
| EBITDA | $364.00M |
| Operating Margin | 11.50% |
| Return on Equity | 3.99% |
| Return on Assets | 2.43% |
| Revenue/Share (TTM) | $40.71 |
| Book Value | $40.84 |
| Price-to-Book | 1.71 |
| Price-to-Sales (TTM) | 1.72 |
| EV/Revenue | 2.297 |
| EV/EBITDA | 11.19 |
| Quarterly Earnings Growth (YoY) | -47.50% |
| Quarterly Revenue Growth (YoY) | 7.30% |
| Shares Outstanding | $45.79M |
| Float | $37.78M |
| % Insiders | 1.18% |
| % Institutions | 119.33% |
Volatility is currently contracting

Ashland Inc. (ASH) Analyst/Investor Day Transcript

Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.

Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026.

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines.

Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers.

WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock.

Ashland Inc. (ASH) Q3 2026 Earnings Call Transcript

Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASH and any ticker you trade — then tracks every position and per-strategy win rate.